WASHINGTON — Sen. Sherrod Brown on Thursday became the latest Democratic presidential hopeful to sign onto aggressive legislation aimed at lowering the cost of prescription drugs.
Brown joined Sen. Tammy Baldwin (D-Wis.) and a slate of Democratic congressmen on a bill that would allow Medicare to negotiate drug prices and strip patent exclusivity from pharmaceutical companies if those negotiations fail. While the bill is not Brown’s first foray into drug pricing policy, it is the strongest indication yet that he, like many other 2020 hopefuls, may begin to take a more aggressive tone on the pharmaceutical industry.
About the Author Reprints
